These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 2426442)
1. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644. Hattori Y; Nakaya H; Tohse N; Kanno M J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442 [TBL] [Abstract][Full Text] [Related]
2. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644. Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301 [TBL] [Abstract][Full Text] [Related]
3. Voltage-dependent effects of YC-170, a dihydropyridine calcium channel modulator, in cardiovascular tissues. Nakaya H; Hattori Y; Tohse N; Kanno M Naunyn Schmiedebergs Arch Pharmacol; 1986 Aug; 333(4):421-30. PubMed ID: 2430192 [TBL] [Abstract][Full Text] [Related]
4. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants. Schramm M; Thomas G; Towart R; Franckowiak G Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037 [TBL] [Abstract][Full Text] [Related]
5. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery. Kanmura Y; Itoh T; Kuriyama H J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390 [TBL] [Abstract][Full Text] [Related]
6. [Single channel analysis of Ca2+ channel-agonistic action of dihydropyridine derivatives: voltage-dependent effects of YC-170 and BAY K 8644]. Takeda Y Hokkaido Igaku Zasshi; 1993 Jul; 68(4):557-69. PubMed ID: 7687975 [TBL] [Abstract][Full Text] [Related]
7. TMB-8 as a pharmacologic tool in guinea pig myocardial tissues. I. Effects of TMB-8 on force of contraction and on action potential parameters in atrial and papillary muscles. Himmel HM; Ravens U J Pharmacol Exp Ther; 1990 Oct; 255(1):293-9. PubMed ID: 1698970 [TBL] [Abstract][Full Text] [Related]
8. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule. Thomas G; Gross R; Schramm M J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776 [TBL] [Abstract][Full Text] [Related]
9. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies. Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate. Yamaura T; Kase N; Kita H; Uematsu T Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142 [TBL] [Abstract][Full Text] [Related]
11. In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644. Rogg H; Criscione L; Truog A; Meier M J Cardiovasc Pharmacol; 1985; 7 Suppl 6():S31-7. PubMed ID: 2414592 [TBL] [Abstract][Full Text] [Related]
12. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries. Asano M; Aoki K; Suzuki Y; Matsuda T J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956 [TBL] [Abstract][Full Text] [Related]
13. PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. Hof RP; Scholtysik G; Loutzenhiser R; Vuorela HJ; Neumann P J Cardiovasc Pharmacol; 1984; 6(3):399-406. PubMed ID: 6202964 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the in vitro and in vivo cardiovascular effects of two structurally distinct Ca++ channel activators, BAY K 8644 and FPL 64176. Rampe D; Anderson B; Rapien-Pryor V; Li T; Dage RC J Pharmacol Exp Ther; 1993 Jun; 265(3):1125-30. PubMed ID: 7685384 [TBL] [Abstract][Full Text] [Related]
15. Stimulation of Ca-dependent action potentials in mammalian ventricular myocardium by a novel dihydropyridine. Nilius B Biomed Biochim Acta; 1984; 43(12):1385-97. PubMed ID: 6085472 [TBL] [Abstract][Full Text] [Related]
16. New 1,4-dihydropyridines with vasoconstrictor action through activation of Ca++-channels. Takenaka T; Inagaki O; Terai M; Asano M; Kubo K J Pharmacol Exp Ther; 1988 Feb; 244(2):699-708. PubMed ID: 2450201 [TBL] [Abstract][Full Text] [Related]
17. A dihydropyridine (Bay k 8644) that enhances calcium currents in guinea pig and calf myocardial cells. A new type of positive inotropic agent. Thomas G; Chung M; Cohen CJ Circ Res; 1985 Jan; 56(1):87-96. PubMed ID: 2578336 [TBL] [Abstract][Full Text] [Related]
18. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle. Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735 [TBL] [Abstract][Full Text] [Related]
19. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro. Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604 [TBL] [Abstract][Full Text] [Related]
20. Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle. Kobayashi M; Ishida Y; Shoji N; Ohizumi Y J Pharmacol Exp Ther; 1988 Aug; 246(2):667-73. PubMed ID: 2457078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]